Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Infiltration of the Leptomeninges by Systemic Cancer:a Clinical & Pathologic Study
Arch Neurol 30:122, Olson,M.E.,et al, 1974
In Patients with Melanoma Brain Metastases, is Combination Immune Checkpoint Inhibition a Safe and Effective First-Line Treatment? A Critically Appraised Topic
Neurologist 27:290-297, Gritsch, D.,et al, 2022
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy
Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016
Ventriculoperitoneal Shunt in Patients with Leptomeningeal Metastasis
Neurol 64:1625-1627, Omuro,A.M.P.,et al, 2005
Brain Metastases
The Neurologist 10:31-46, Klos,K.J.&O'Neill,B.P., 2004
Meningeal Carcinomatosis
Arch Neurol 38:696-699, Theodore,W.H.,et al, 1981
Primary Diffuse Leptomeningeal Melanocytosis, A Diagnoatic Conundrum
Neurol 101:e576-3580, Selvarajan,J.M.P.,et al, 2023
Myasthenia Gravis Following Dabrafenib and Trametinib for Metastatic Melanoma
Neurol 94:322-323, Zaloum, A.,et al, 2020
Association of Innovations in Radiotherapy and Systemic Treatments with Clinical Outcomes in Patients with Melanoma Brain Metastasis From 2007 to 2016
JAMA doi:10.1001/JAMANETWORKOPEN.2020.8204, Brastianos, H.C.,et al, 2020
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
NEJM 379:722-730,789, Tawbi, H.A.,et al, 2018
Pembrolizumab-Induced Myasthenia Gravis
Neurol 91:e1365-e1367, Algaeed, M.,et al, 2018
Inflammatory Demyelinating Polyneuropathy Versus Leptomeningeal Disease Following Ipilimumab
J Immunother Cancer 6:11, Cafuir, L.,et al, 2018
Five Cases of Malignant Melanoma During Fingolimod Treatment in Dutch Patients with MS
Neurol 89:970-972, Killestein, J.,et al, 2017
Neurocutaneous Melanosis with Diffuse Leptomeningeal Malignant Melanoma in an Adult
Neurol 86:e75-e79, Bhatia, R.,et al, 2016
Intracranial Lesions with High Signal Intensity on T1-weighted MR images - Review of Pathologies
Pol J Radiol 78:36-46, Zimmy, Anna.,et al, 2013
Neurological Immune-Related Adverse Events of Ipilimumab
Pract Neurol 13:278-280, Bot, I.,et al, 2013
Vemurafenib for Melanoma Metastases to the Brain
NEJM 365:2439-2441, Rochet, N.M.,et al, 2011
Leptomeningeal Metastases in the MRI Era
Neurol 74:1449-1454, Clarke,J.L., et al, 2010
Melanoma Complicating Treatment with Natalizumab for Multiple Sclerosis
NEJM 358:647-648, Mullen,J.T.,et al, 2008
A Diagnostic Approach to Multiple Simultaneous Intracerebral Hemorrhages
Neurocrit Care 4:267-271, Finelli,P.F., 2006
Treatment of Brain Metastases of Malignant Melanoma with Temozolomide
NEJM 345:621-622, Biasco,G.,et al, 2001
Neurology and the Skin
JNNP 66:417-430, Hurko,O.&Provost,T.T., 1999
Intracranial Metastatic Melanoma:Correlation Between MR Imaging Characteristics and Melanin Content
AJR 165:1503-1512, Isiklar,I.,et al, 1995
Intracranial Metastatic Melanoma:Correlation Between MR Imaging Characteristics and Melanin Content
AJR 165:1503-1512, Isiklar,I.,et al, 1995
Central Nervous System Involvement in Malignant Melanoma
Cancer 61:1926-1934, Retsas,S.&Gershuny,A.R., 1988
Computed Tomography in Metastatic Disease of the Brain
Radiology 119:115-120, Deck,M.D.F.,et al, 1976